US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
オーストラリア
ASX
Avecho Biotechnology Limited (AVEOA) 銘柄情報

Avecho Biotechnology Limited (AVEOA)

0.001

0.00

(0.00%)

終了 6月7日 3:00PM

Avecho Biotechnology Limited (AVEOA) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.001

( - )

買値

0.00

売値

0.001

出来高

0.00

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

0.001

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 8,293,362

発行済株式数

3,830,448,257

配当利回り

PER

-8.57

1 株当たり利益 (EPS)

-0

歳入

1.24M

純利益

-4.42M

Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India. It operates through Production and Human Health segments. T... Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. Its human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. In addition, the company develops pharmaceutical products; oral, topical, and edible pharmaceutical cannabinoid products, including a cannabidiol TPM soft-gel capsule in Phase III clinical trial for the treatment of insomnia; and non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

avecho.com.au

本社

Clayton, Australia

設立

1992

Avecho Biotechnology Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker AVEOA. The last closing price for Avecho Biotechnology was AUD0. Over the last year, Avecho Biotechnology shares have traded in a share price range of AUD 0.00 to AUD 0.00.

Avecho Biotechnology currently has 3,830,448,257 shares in issue. The market capitalisation of Avecho Biotechnology is AUD3.83 million. Avecho Biotechnology has a price to earnings ratio (PE ratio) of -8.57.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

AVEOA - Frequently Asked Questions (FAQ)

What is the current Avecho Biotechnology Limited share price?

The current share price of Avecho Biotechnology Limited is AUD 0.001

How many Avecho Biotechnology Limited shares are in issue?

Avecho Biotechnology Limited has 3,830,448,257 shares in issue

What is the market cap of Avecho Biotechnology Limited?

The market capitalisation of Avecho Biotechnology Limited is AUD 3.83M

What is the 1 year trading range for Avecho Biotechnology Limited share price?

Avecho Biotechnology Limited has traded in the range of AUD 0.00 to AUD 0.00 during the past year

What is the PE ratio of Avecho Biotechnology Limited?

The price to earnings ratio of Avecho Biotechnology Limited is -8.57

What is the cash to sales ratio of Avecho Biotechnology Limited?

The cash to sales ratio of Avecho Biotechnology Limited is 37.14

What is the registered address of Avecho Biotechnology Limited?

The registered address for Avecho Biotechnology Limited is Hallmarc Business Park, Clayton, Victoria, 3168

What is the Avecho Biotechnology Limited website address?

The website address for Avecho Biotechnology Limited is avecho.com.au

Which industry sector does Avecho Biotechnology Limited operate in?

Avecho Biotechnology Limited operates in the Biotechnology & Life Sciences sector

uber darthium

uber darthium 2分前

May I predict that the families of these AMFN BAGHOLDERS will more likely than not be stepping in during the coming weeks to do whatever to protect themselves and their families’ financial future and set up my internal controls preventing these “old” sheep from “investing” in the insider enrichment

jerkviewer

jerkviewer 4分前

if we dont sell....can you imagine us making about 500 million a month in a few years.....boom

EddytheEagle

EddytheEagle 4分前

Direct has been sitting on the back shelf for 10 years now. That doesn't exactly give it blockbuster status. Good luck with that. And as for -L, its been 2 1/2 yrs since they filed for approval. Good luck with that too.

waterchaser

waterchaser 7分前

jerkviewer

jerkviewer 9分前

apparently this eloquis filing could be raising the price tag of elite several times..... if they can get the big boys to even believe just a little that it could happen and we could get around the patents...then we could get a bidding war or at least a damn good price

Rhodan

Rhodan 10分前

Where is that Return to Service guidance reported? Delfin marches forward in an arrow straight line.

Stumblebum

Stumblebum 13分前

Still holding BMEA 💵💰

Duke Knockem

Duke Knockem 14分前

he publicly mentioned on Twitter and here that he loaded ENCC... I had pinned his comment screenshot on here on the board when I was a moderator but somehow someone deleted all of my pinned pictures related to this security.

Mr. C

What? They probably already did and I highly doubt that has anything to do with merger versus preventing the FID that we just got.

Keep in mind, it takes well over a year to clear those cases, so it isn’t going anywhere, but that does not mean they didn’t receive a return to service w

TooFrank

TooFrank 14分前

NIO has no exposure, Wall Street has no discernment.

The European Union and China are edging closer to a full-scale trade war as the bloc moves to protect its struggling manufacturing sector from a massive surge of subsidized Chinese imports.
Over a recent five-year period, Ch

Optimus Research

Optimus Research 15分前

Linda Powers will be a trillionaire before Elon Musk. How do you like them apples??

Cambreau

Cambreau 15分前

Wouldn't be surprised if this dips sub .50 like it did end of 2022. Very frustrating , to say the least.

WhiteOwl

WhiteOwl 16分前

There seems to be more of the Ignores posting than what I consider to be legitimate Posters. JMHO

THE OLD OWL 🦉🦉🦉

Rhodan

Rhodan 18分前

PHSMA needs to clear. I am sure it will, just a matter of when.

learningcurve2020

learningcurve2020 22分前

Yeah, going about as well as that California bullet train. LOL. Where’d all that cash go anyway? Maybe consultants? 🤔

https://www.commerce.senate.gov/press/rep/release/after-25-years-and-billions-in-federal-subsidies-not-a-single-train-operating-in-california/

jimr1717

jimr1717 23分前

Word salad nonsense. Only Fools are fooled

3antar

3antar 28分前

Not in a rush for IPO, does not mean no uplisting soon. Bill Ackman said a few months ago uplist comes first. So we should be fine!

Doc logic

Doc logic 30分前

learningcurve2020,

Gotta lay the track before the train can roll, even the high speed trains; ). Best wishes.

Genz2

Hey Methinks, wouldn’t it be something if Steven Sprague became super famous, and he invited all his business leader friends to his farm to pet the horses and SAVE THE FARM!!! I think that would be kind of COOL!!! What do you think??

DewDiligence

DewDiligence 33分前

Thanks, flo, and go_seek. I was able to listen after I disabled my ad-blocking utility.

mascale

mascale 38分前

Compare Qatar validated public record v. IHUB post(s).

price_and_volume

price_and_volume 39分前

Anyone who feels they were misled into losses:
YOU ALL NEED TO FILE COMPLAINTS ON THE $OTC WEB SITE AND THE $FINRA WEB SITE Use the https://www.sec.gov/submit-tip-or-complaint/tips-complaints-resources/report-suspected-securities-fraud-or-wrongdoing SEC Enforcement & Complaint Form

misterfishman

misterfishman 41分前

If its been 5 yrs then 2026 could be our year after all.

learningcurve2020

learningcurve2020 42分前

Direct? You and Guru are sure putting a lot of faith in a vaccine that hasn’t even been tested. LOL. Add to it LP knows nothing about delivering ROI to shareholders. Zero track record. And as Eddie says competition is now all over the place. But you two live in a NWBO vacuum where none of that matt

tkg

Strategically, the use of electro-optic polymers offers a “leap-frog” technology for quantum photonics. Unlike traditional materials, these polymers can be processed using standard silicon fab-compatible methods while providing the rapid refractive index modulation necessary for high-speed quantum s

Avecho Biotechnology

Regular Interest Fixed C...

Ci International Value F...

Bmo Growth and Income Fu...

Industrial Bank Of Korea

Banco Bilbao Vizcaya Arg...

Adtran Networks

Ci Canadian Dividend Cor...

Hybrid Minerals

Quantum Graphite

Brompton Oil Split

Chatham Lodging

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。